PI
TMO icon

PEAK6 Investments’s Thermo Fisher Scientific TMO Stock Holding History

PEAK6 Investments’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$3.84M Sell
6,200
-11,800
-66% -$6.99M 0.01% 1101
2024
Q2 		$9.95M Buy
18,000
+14,100
+362% +$8.08M 0.03% 499
2024
Q1 		$2.27M Sell
3,900
-4,800
-55% -$2.69M 0.01% 1335
2023
Q4 		$4.62M Buy
8,700
+4,900
+129% +$2.37M 0.02% 909
2023
Q3 		$1.92M Buy
3,800
+2,200
+138% +$1.17M 0.01% 1359
2023
Q2 		$835K Sell
1,600
-17,700
-92% -$9.55M ﹤0.01% 1826
2023
Q1 		$11.1M Buy
19,300
+8,000
+71% +$4.51M 0.05% 345
2022
Q4 		$6.22M Sell
11,300
-4,600
-29% -$2.44M 0.04% 588
2022
Q3 		$8.06M Buy
15,900
+13,100
+468% +$7.33M 0.03% 552
2022
Q2 		$1.49M Sell
2,800
-49,800
-95% -$27.4M ﹤0.01% 2651
2022
Q1 		$31.1M Sell
52,600
-12,900
-20% -$7.41M 0.07% 269
2021
Q4 		$43.7M Sell
65,500
-12,200
-16% -$7.62M 0.09% 202
2021
Q3 		$44.4M Buy
77,700
+59,829
+335% +$32.8M 0.1% 171
2021
Q2 		$17.6M Buy
17,871
+5,971
+50% +$2.82M 0.04% 423
2021
Q1 		$5.43M Sell
11,900
-49,600
-81% -$23.7M 0.01% 989
2020
Q4 		$28.6M Sell
61,500
-7,000
-10% -$3.28M 0.06% 289
2020
Q3 		$30.2M Buy
68,500
+55,800
+439% +$23.1M 0.07% 230
2020
Q2 		$4.6M Buy
12,700
+7,700
+154% +$2.58M 0.02% 869
2020
Q1 		$1.42M Buy
5,000
+4,000
+400% +$1.26M 0.01% 1268
2019
Q4 		$325K Hold
1,000
– – ﹤0.01% 2240
2019
Q3 		$291K Sell
1,000
-700
-41% -$200K ﹤0.01% 2660
2019
Q2 		$499K Sell
1,700
-19,000
-92% -$5.23M ﹤0.01% 2265
2019
Q1 		$5.67M Sell
20,700
-56,700
-73% -$14.1M 0.03% 641
2018
Q4 		$17.3M Buy
77,400
+22,000
+40% +$5.16M 0.11% 176
2018
Q3 		$13.5M Buy
+55,400
New +$12.7M 0.06% 346

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PEAK6 Investments's TMO Position: Q3 2024 in Review

PEAK6 Investments reduced its Thermo Fisher Scientific (TMO) stake by 100% in Q3 2024, selling an estimated $2.52M and leaving 3 shares worth $1.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3315.

PEAK6 Investments first reported a position in TMO in Q4 2018 and has held it in 19 quarters since. The position peaked at $11.4M in Q4 2020. 2,568 funds tracked by Wall St. Rank hold TMO as of Q3 2024.

  • PEAK6 Investments held 3 shares of Thermo Fisher Scientific worth $1.6K as of Q3 2024.
  • PEAK6 Investments sold 4,259 Thermo Fisher Scientific shares in Q3 2024, an estimated $2.52M.
  • Thermo Fisher Scientific made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #3315 holding.
  • PEAK6 Investments first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 19 quarters since.
  • PEAK6 Investments's Thermo Fisher Scientific position peaked at $11.4M in Q4 2020.
  • 2,568 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.